Financial News
Articles published by Telix Pharmaceuticals Limited
Telix Completes Acquisition of RLS (USA) Inc.
January 27, 2025
Via GlobeNewswire
Illuccix® Receives European Approval
January 16, 2025
Via GlobeNewswire
Via GlobeNewswire
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
January 13, 2025
Via GlobeNewswire
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
December 29, 2024
Via GlobeNewswire
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
November 18, 2024
Via GlobeNewswire
Telix ADSs Commence Trading on Nasdaq
November 13, 2024
Via GlobeNewswire
Via GlobeNewswire
Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals
November 03, 2024
Via GlobeNewswire
Tickers
ASX:TLX
Via GlobeNewswire
Tickers
ASX:TLX
Telix Files Form 20-F Registration Statement for Nasdaq ADS
October 17, 2024
Via GlobeNewswire
Tickers
ASX:TLX
Telix Q3 2024 Business Update – Quarterly Revenue Exceeds AU$200M
October 17, 2024
Via GlobeNewswire
Tickers
ASX:TLX
Telix to Acquire RLS to Expand North American Manufacturing and Distribution Platform
September 22, 2024
Via GlobeNewswire
Tickers
ASX:TLX
Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
September 17, 2024
Via GlobeNewswire
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
September 03, 2024
Via GlobeNewswire
Tickers
ASX:TLX
Via GlobeNewswire
Tickers
ASX:TLX
Via GlobeNewswire
Tickers
ASX:TLX
Via GlobeNewswire
Tickers
ASX:TLX
Via GlobeNewswire
Tickers
ASX:TLX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.